Nikita Singh / Tuesday, May 15, 2018 / Categories: Trending, Markets Sun Pharma stock continues decline on falling sales figure The share price of pharmaceutical major Sun Pharma plunged by over 7 per cent during the previous week on the back of declining sales of its key specialty products and speculation about price erosion. Specialty products constitute a major part of the company ’s total sales. According to reports, the company has recorded a decline in drug sales by 26 per cent in the fourth quarter of FY18 on a year-on-year basis. In Tuesday ’s trade, the stock hit an intra-day low of Rs. 459.45, down by 3 per cent and an intra-day high of Rs. 479.95 on the BSE. The stock recorded a spurt in volume by over 1.71 times as compared with its average volume during the trading. The stock had touched its 52-week low of Rs 433.15 on August 14, 2017 and its 52-week high of Rs 657.95 on May 15, 2017 on the BSE, respectively. The stock ended at Rs. 468.25 per share, down by 1.22 per cent on BSE on Tuesday. Meanwhile, S&P BSE Sensex closed at 35,543.94 level, down by 0.04 per cent and NSE Nifty50 ended at 10,801.85 level, down by 0.04 per cent, respectively. Previous Article Simple rules to enhance your MF investments Next Article Markets may slide further as BJP misses majority mark in Karnataka Print 3071 Rate this article: 3.7 Please login or register to post comments.